Cargando…

Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions

Young onset Alzheimer’s disease (YOAD) is defined as symptom onset before the age of 65 years and is particularly associated with phenotypic heterogeneity. Atypical presentations, such as the clinic-radiological visual syndrome posterior cortical atrophy (PCA), often lead to delays in accurate diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavisic, Ivanna M., Firth, Nicholas C., Parsons, Samuel, Rego, David Martinez, Shakespeare, Timothy J., Yong, Keir X. X., Slattery, Catherine F., Paterson, Ross W., Foulkes, Alexander J. M., Macpherson, Kirsty, Carton, Amelia M., Alexander, Daniel C., Shawe-Taylor, John, Fox, Nick C., Schott, Jonathan M., Crutch, Sebastian J., Primativo, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545969/
https://www.ncbi.nlm.nih.gov/pubmed/28824534
http://dx.doi.org/10.3389/fneur.2017.00377
_version_ 1783255515262877696
author Pavisic, Ivanna M.
Firth, Nicholas C.
Parsons, Samuel
Rego, David Martinez
Shakespeare, Timothy J.
Yong, Keir X. X.
Slattery, Catherine F.
Paterson, Ross W.
Foulkes, Alexander J. M.
Macpherson, Kirsty
Carton, Amelia M.
Alexander, Daniel C.
Shawe-Taylor, John
Fox, Nick C.
Schott, Jonathan M.
Crutch, Sebastian J.
Primativo, Silvia
author_facet Pavisic, Ivanna M.
Firth, Nicholas C.
Parsons, Samuel
Rego, David Martinez
Shakespeare, Timothy J.
Yong, Keir X. X.
Slattery, Catherine F.
Paterson, Ross W.
Foulkes, Alexander J. M.
Macpherson, Kirsty
Carton, Amelia M.
Alexander, Daniel C.
Shawe-Taylor, John
Fox, Nick C.
Schott, Jonathan M.
Crutch, Sebastian J.
Primativo, Silvia
author_sort Pavisic, Ivanna M.
collection PubMed
description Young onset Alzheimer’s disease (YOAD) is defined as symptom onset before the age of 65 years and is particularly associated with phenotypic heterogeneity. Atypical presentations, such as the clinic-radiological visual syndrome posterior cortical atrophy (PCA), often lead to delays in accurate diagnosis. Eyetracking has been used to demonstrate basic oculomotor impairments in individuals with dementia. In the present study, we aim to explore the relationship between eyetracking metrics and standard tests of visual cognition in individuals with YOAD. Fifty-seven participants were included: 36 individuals with YOAD (n = 26 typical AD; n = 10 PCA) and 21 age-matched healthy controls. Participants completed three eyetracking experiments: fixation, pro-saccade, and smooth pursuit tasks. Summary metrics were used as outcome measures and their predictive value explored looking at correlations with visuoperceptual and visuospatial metrics. Significant correlations between eyetracking metrics and standard visual cognitive estimates are reported. A machine-learning approach using a classification method based on the smooth pursuit raw eyetracking data discriminates with approximately 95% accuracy patients and controls in cross-validation tests. Results suggest that the eyetracking paradigms of a relatively simple and specific nature provide measures not only reflecting basic oculomotor characteristics but also predicting higher order visuospatial and visuoperceptual impairments. Eyetracking measures can represent extremely useful markers during the diagnostic phase and may be exploited as potential outcome measures for clinical trials.
format Online
Article
Text
id pubmed-5545969
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-55459692017-08-18 Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions Pavisic, Ivanna M. Firth, Nicholas C. Parsons, Samuel Rego, David Martinez Shakespeare, Timothy J. Yong, Keir X. X. Slattery, Catherine F. Paterson, Ross W. Foulkes, Alexander J. M. Macpherson, Kirsty Carton, Amelia M. Alexander, Daniel C. Shawe-Taylor, John Fox, Nick C. Schott, Jonathan M. Crutch, Sebastian J. Primativo, Silvia Front Neurol Neuroscience Young onset Alzheimer’s disease (YOAD) is defined as symptom onset before the age of 65 years and is particularly associated with phenotypic heterogeneity. Atypical presentations, such as the clinic-radiological visual syndrome posterior cortical atrophy (PCA), often lead to delays in accurate diagnosis. Eyetracking has been used to demonstrate basic oculomotor impairments in individuals with dementia. In the present study, we aim to explore the relationship between eyetracking metrics and standard tests of visual cognition in individuals with YOAD. Fifty-seven participants were included: 36 individuals with YOAD (n = 26 typical AD; n = 10 PCA) and 21 age-matched healthy controls. Participants completed three eyetracking experiments: fixation, pro-saccade, and smooth pursuit tasks. Summary metrics were used as outcome measures and their predictive value explored looking at correlations with visuoperceptual and visuospatial metrics. Significant correlations between eyetracking metrics and standard visual cognitive estimates are reported. A machine-learning approach using a classification method based on the smooth pursuit raw eyetracking data discriminates with approximately 95% accuracy patients and controls in cross-validation tests. Results suggest that the eyetracking paradigms of a relatively simple and specific nature provide measures not only reflecting basic oculomotor characteristics but also predicting higher order visuospatial and visuoperceptual impairments. Eyetracking measures can represent extremely useful markers during the diagnostic phase and may be exploited as potential outcome measures for clinical trials. Frontiers Media S.A. 2017-08-07 /pmc/articles/PMC5545969/ /pubmed/28824534 http://dx.doi.org/10.3389/fneur.2017.00377 Text en Copyright © 2017 Pavisic, Firth, Parsons, Rego, Shakespeare, Yong, Slattery, Paterson, Foulkes, Macpherson, Carton, Alexander, Shawe-Taylor, Fox, Schott, Crutch and Primativo. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Pavisic, Ivanna M.
Firth, Nicholas C.
Parsons, Samuel
Rego, David Martinez
Shakespeare, Timothy J.
Yong, Keir X. X.
Slattery, Catherine F.
Paterson, Ross W.
Foulkes, Alexander J. M.
Macpherson, Kirsty
Carton, Amelia M.
Alexander, Daniel C.
Shawe-Taylor, John
Fox, Nick C.
Schott, Jonathan M.
Crutch, Sebastian J.
Primativo, Silvia
Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions
title Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions
title_full Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions
title_fullStr Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions
title_full_unstemmed Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions
title_short Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions
title_sort eyetracking metrics in young onset alzheimer’s disease: a window into cognitive visual functions
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545969/
https://www.ncbi.nlm.nih.gov/pubmed/28824534
http://dx.doi.org/10.3389/fneur.2017.00377
work_keys_str_mv AT pavisicivannam eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions
AT firthnicholasc eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions
AT parsonssamuel eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions
AT regodavidmartinez eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions
AT shakespearetimothyj eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions
AT yongkeirxx eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions
AT slatterycatherinef eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions
AT patersonrossw eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions
AT foulkesalexanderjm eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions
AT macphersonkirsty eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions
AT cartonameliam eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions
AT alexanderdanielc eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions
AT shawetaylorjohn eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions
AT foxnickc eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions
AT schottjonathanm eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions
AT crutchsebastianj eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions
AT primativosilvia eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions